We are live on
!
Find out more
Tudor Investment Corp Portfolio holdings
AUM
$53.9B
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
-1.47%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$19.5B
AUM Growth
+$3.8B
(+24%)
Cap. Flow
+$4.18B
Cap. Flow
% of AUM
21.4%
Top 10 Holdings %
Top 10 Hldgs %
34.26%
Holding
2,929
New
786
Increased
755
Reduced
667
Closed
671
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
PUT
Globe Life
GL
$14B
| $1.66M | 0.01% |
+20,200
| New | +$1.67M |
|
1177
Dyne Therapeutics
DYN
$4.85B
| $1.66M | 0.01% |
47,069
-9,892
| -17% | -$287K |
|
1178
Acadia Pharmaceuticals
ACAD
$4.89B
| $1.66M | 0.01% |
101,972
+26,484
| +35% | +$427K |
|
1179
iShares Biotechnology ETF
IBB
$9.77B
| $1.65M | 0.01% |
+12,057
| New | +$1.61M |
|
1180
CALL
Clorox
CLX
$12.9B
| $1.65M | 0.01% |
12,100
-30,400
| -72% | -$4.22M |
|
1181
iShares Russell 1000 Growth ETF
IWF
$129B
| $1.65M | 0.01% |
+18,092
| New | +$1.54M |
|
1182
PUT
Monolithic Power Systems
MPWR
$67B
| $1.64M | 0.01% |
2,000
+400
| +25% | +$289K |
|
1183
Theravance Biopharma
TBPH
$878M
| $1.64M | 0.01% |
193,768
+16,156
| +9% | +$146K |
|
1184
CALL
Cloudflare
NET
$118B
| $1.64M | 0.01% |
19,800
-98,200
| -83% | -$7.92M |
|
1185
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.81B
| $1.64M | 0.01% |
+46,096
| New | +$1.62M |
|
|
INN
1186
Summit Hotel Properties
INN
$656M
| $1.64M | 0.01% |
273,536
+70,566
| +35% | +$432K |
|
1187
Community Health Systems
CYH
$419M
| $1.63M | 0.01% |
485,978
+7,888
| +2% | +$26.5K |
|
1188
PUT
Carpenter Technology
CRS
$26.6B
| $1.63M | 0.01% |
+14,900
| New | +$1.43M |
|
1189
LXP Industrial Trust
LXP
$3.58B
| $1.63M | 0.01% |
+35,798
| New | +$1.57M |
|
1190
CALL
UnitedHealth
UNH
$358B
| $1.63M | 0.01% |
3,200
-7,900
| -71% | -$3.87M |
|
1191
PTC Therapeutics
PTCT
$6.01B
| $1.63M | 0.01% |
53,161
+24,687
| +87% | +$800K |
|
1192
CACI
CACI
$14.8B
| $1.62M | 0.01% |
3,777
-11,451
| -75% | -$4.68M |
|
1193
Crescent Capital BDC
CCAP
$417M
| $1.62M | 0.01% |
86,352
+44,558
| +107% | +$796K |
|
1194
Arcosa
ACA
$7.12B
| $1.62M | 0.01% |
19,439
-69,599
| -78% | -$5.8M |
|
1195
CALL
VeriSign
VRSN
$26B
| $1.62M | 0.01% |
+9,100
| New | +$1.62M |
|
1196
Pennant Group
PNTG
$1.35B
| $1.62M | 0.01% |
69,743
+55,710
| +397% | +$1.22M |
|
1197
Omega Healthcare
OHI
$13.9B
| $1.61M | 0.01% |
47,116
-831
| -2% | -$26.2K |
|
1198
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $1.61M | 0.01% |
17,355
-94,527
| -84% | -$8.48M |
|
1199
Vanguard Total International Stock ETF
VXUS
$164B
| $1.61M | 0.01% |
+26,657
| New | +$1.61M |
|
1200
CALL
HCA Healthcare
HCA
$89.1B
| $1.61M | 0.01% |
5,000
-900
| -15% | -$292K |
|
Similar funds
SCP
Tudor Investment Corp's Q2 2024 Portfolio in Review
As of Q2 2024, Tudor Investment Corp held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Tudor Investment Corp deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Tudor Investment Corp's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Tudor Investment Corp added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Tudor Investment Corp's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Tudor Investment Corp fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Tudor Investment Corp's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Tudor Investment Corp opened 786 new positions and closed 671 in Q2 2024.
- Tudor Investment Corp's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.